This study is looking at how well a special imaging scan, called [18F]FES PET/CT, can find estrogen receptor (ER) activity in uterine cancer. This scan uses a small amount of a radioactive tracer ([18F]fluoroestradiol) to highlight areas where cancer cells might be growing. You might be able to join if you are a woman at least 18 years old with uterine cancer that has come back, spread, or hasn't been treated with surgery, and has been confirmed by a biopsy or other scans. The study aims to see how often this scan shows positive results for ER+ (estrogen receptor positive) uterine cancer after one year. The study plans to enroll up to 30 participants, but its current recruitment status is unclear.

Study design

This is a Phase II interventional study, meaning it tests a specific intervention in a small group of people. It plans to enroll up to 30 women.

What's involved

If you join, you will have an [18F]FES PET/CT scan. This scan will happen before you start any new cancer treatment.

Compensation

Not stated in the trial record.

Follow-up

The primary outcome of the study, FES positivity, is measured at 1 year.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.